Pushing Against the QALY Criticism in Drug Pricing

Health Affairs Editor-in-Chief Alan Weil interviews Leah Rand, a postdoctoral fellow at Harvard Medical School and Brigham and Women’s Hospital, on the pros and cons of the Quality Adjusted Life Year (QALY) measurement in health policy.